Table 2.
Angioirritative potential of antiseptics in long term application
| Product™ | Substance | Reaction | Time [min] |
|---|---|---|---|
| negative controls | |||
| Rinsing solutions | 0,9% physiological saline, Ringer solution | no | 60 |
| Buffered solution | PBS | no | 60 |
| positive control | |||
| 1% SDS | Sodium dodecyl sulfat | severe | 5 |
| solutions: | |||
| Dettol™ | 0.35% chloroxylenol + 0.8% denaturated alcohol | severe | 5 |
| Cutasept™ | 72% isopropanol | severe | 5 |
| Octenisept™ | 0.1% octenidin - 2HCL | severe | 5 |
| Betaisodona™ | 10% PVP-I | severe | 60 |
| Betaisodona™ 1:10 | 1% PVP-I | severe | 60 |
| Prontosan™ | 0.1% polyhexanid | severe | 60 |
| Lavanid™ | 0.04% polyhexanid | no | 60 |
| MDT | sterile washings from Lucilia sericata maggots | no | 60 |
| Ointments, pellets | |||
| Iruxol-n™ | Enzyme filtrations from Clostridium histolyticum | no | 5 |
| Flammazine™ | 1% silver-sulfadiazine | slight | 5 |
| Betaisodona™ ointment | 10% PVP-I | severe | 5 |
| Repithel™ | 3% lysosomal PVP-I | moderate | 60 |
| Iodosorb™ | 1,8% cadexomer-iodine | moderate | 60 |
| Iodosorb™ Pellets | 1% cadexomer-iodine | moderate | 60 |